Basilea Pharmaceutica AG
BPMUF
$67.75
$6.4110.45%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.46% | -25.89% | 368.03% | 371.43% | -35.26% |
| Total Depreciation and Amortization | 30.87% | 16.14% | 0.07% | 1.34% | 10.68% |
| Total Amortization of Deferred Charges | 8.70% | -3.57% | -56.39% | -55.82% | -37.61% |
| Total Other Non-Cash Items | 170.47% | 162.52% | -427.02% | -431.20% | -577.55% |
| Change in Net Operating Assets | -111.05% | -109.80% | -98.55% | -98.53% | 145.38% |
| Cash from Operations | 41.04% | 25.13% | 846.96% | 856.47% | -18.53% |
| Capital Expenditure | 24.63% | 33.17% | -151.14% | -154.34% | -47.80% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -92.49% | -70.63% | 79.98% | 79.69% | 29.74% |
| Cash from Investing | -273.87% | -254.25% | -98.85% | -101.40% | 166.68% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 100.00% | 100.00% | 15.33% |
| Issuance of Common Stock | -78.08% | -78.08% | -85.96% | -85.96% | 61.30% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -10,219.59% | -10,219.59% | 55.99% | 55.99% | 268.18% |
| Cash from Financing | -20.70% | -7.09% | 99.94% | 99.94% | 23.53% |
| Foreign Exchange rate Adjustments | -111.11% | -109.79% | 57.20% | 56.67% | 1,000.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 73.78% | 54.18% | 214.23% | 215.69% | 16.81% |